Our defective drug lawyers at Sullivan & Brill, LLP are currently investigating
the legal claims that may be brought by individuals who have been injured
from the nationwide outbreak of fungal spinal meningitis arising out of
contaminated and recalled epidural steroid injections. As of December
6, 2012, the
Centers for Disease Control and Prevention (CDC) is reporting that 541 people in 19 states, including New York, have contracted meningitis
and 36 people have died.
For a list and map of the states affected,
Symptoms that one may be infected with fungal meningitis include:
- Stiffness of the neck
- Neurological deficits, such as confusion, dizziness, slurred speech, and
discomfort from bright lights, which may be caused by deep brain stroke
These symptoms typically appear 1 to 4 weeks following the injection of
the tainted drug and may be very mild at first, but if left untreated,
could result in permanent neurological damage or death.
New York City Injury Attorneys
Since 2001, our
dangerous drug injury lawyers at Sullivan & Brill, LLP have been helping New Yorkers obtain just
compensation for injuries sustained or loved ones lost due to the 2012
Fungal Meningitis outbreak from tainted steroids. Call us now for a
According to the CDC, the potentially contaminated injections where given
starting May 21, 2012. The
FDA is reporting that as many as 14,000 patients have may have been exposed
to fungal meningitis from the tainted epidural steroid injections. On
September 26, 2012, the apparent manufacturer of the contaminated injections,
the New England Compounding Center (NECC),
recalled three lots of preservative-free methylprednisolone acetate (80mg/ml),
the drug in the contaminated epidural steroid injections.
For a complete list and state-by-state map of the facilities that received
. This recall was
expanded to include all products in circulation that were compounded at and distributed
from NECC's facility in Framingham, Massachusetts. On October 16,
2012, criminal investigators from the FDA, CDC officials, and local police
seized records from NECC's facility in Framingham, and members of
Congress began seeking documents from the FDA regarding its oversight
of NECC, according to the
House of Representatives Energy and Commerce Committee.
The fungal meningitis outbreak was first identified by Dr. April Pettit
at Vanderbilt University in Nashville, Tennessee. In September 2012, she
treated a patient with a rare fungal infection in her spine. This patient
had recently received an epidural steroid injection. Dr. Pettit informed
the CDC and the Food and Drug Administration (FDA) of the patient's
fungal meningitis and its connection to an epidural spinal injection.
The CDC and the FDA were able to connect the patient's fungal meningitis
with fungus from methylprednisolone compounded by NECC. The CDC and the
FDA reported that methylprednisolone acetate compounded at the NECC may
contain a fungus, aspergillus fumigatus, which leads to fungal meningitis.
On October 3, 2012, the New England Compounding Center ceased all production
and surrendered its license to the Massachusetts Board of Registration
in Pharmacy. On October 4, 2012, the
CDC and the FDA recommended that all healthcare professionals cease using any product produced by NECC.
Epidural steroid injections are a common treatment for many forms of neck
and back pain. This treatment involves a combination of a corticosteroid
with a local anesthetic pain relief medicine. Corticosteroids are anti-inflammatory
medicines used to relieve pain. Methylprednisolone acetate is a corticosteroid
hormone used to treat pain and swelling that occurs with arthritis and
other joint disorders. The New England Compounding Center compounded and
sold methylprednisolone acetate to doctors and other medical providers
in 23 states for epidural steroid injections.
If you or a loved one has recently received epidural steroid injections
and are experiencing any of the symptoms mentioned above, you should immediately
consult your physician and then contact our personal injury lawyers at
Sullivan & Brill, LLP. Our team is knowledgeable about this
drug recall and we are accepting clients that have contracted fungal meningitis from
these contaminated injections. We expect to file lawsuits against the
manufacturer and hold it accountable for the harm it has caused.